Answers are grounded in this paper and cite their sources.
Mycobacterium tuberculosis presents unique challenges in the peritransplant period. Here, we describe a case of disseminated tuberculosis following renal transplantation with alemtuzumab induction immunosuppression in a patient with remotely treated pulmonary tuberculosis and ongoing risk factors for re-infection. We also review the available literature regarding the prevalence of tuberculosis infection following solid organ transplant and management of high-risk patients, including the role for isoniazid preventative therapy.
No takes yet. Share an insight, caveat, or question.
Baghban et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: